Form 4: Emergent BioSolutions Director Sells 14,287 Shares

Marvin L. White, a director at Emergent BioSolutions Inc., sold 14,287 shares of common stock on November 11, 2024.

Summary

• Marvin L. White, a director of Emergent BioSolutions Inc., sold 14,287 shares of the company's common stock on November 11, 2024.
• The shares were sold at a weighted average price of $11.97 per share.
• The sale was executed within a price range of $11.84 to $12.11.
• Following the transaction, Mr. White beneficially owns 54,092 shares of Emergent BioSolutions Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no inherent positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider trading.
• The sale by Mr. White is similar to other insider transactions reported by directors and officers of public companies.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Emergent BioSolutions, insider trading, stock sale, director, EBS, share transaction